Luis Almenar Bonet
Overview
Explore the profile of Luis Almenar Bonet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
1034
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lopez-Vilella R, Guerrero Cervera B, Donoso Trenado V, Sanchez-Lazaro I, Dolz L, Almenar Bonet L
Life (Basel)
. 2023 Apr;
13(4).
PMID: 37109444
Background: This study aims to analyse whether in acute heart failure (AHF) with iron deficiency (ID), the administration of ferric carboxymaltose (FCM) produces a greater benefit in renal dysfunction. Methods:...
12.
Lopez-Vilella R, Jover Pastor P, Donoso Trenado V, Sanchez-Lazaro I, Barge Caballero E, Crespo-Leiro M, et al.
Am J Cardiol
. 2023 Apr;
196:59-66.
PMID: 37088048
It is not clear to date whether a first admission in heart failure (HF) marks a worse evolution in patients not previously diagnosed with HF ("de novo HF") than those...
13.
Lopez-Vilella R, Jover Pastor P, Donoso Trenado V, Sanchez-Lazaro I, Dolz L, Almenar Bonet L
Hellenic J Cardiol
. 2023 Apr;
73:1-7.
PMID: 37068639
Background: The treatment of congestion in heart failure (HF) is a challenge despite the therapeutic arsenal available. The aim of this study was to analyze different combinations of diuretics used...
14.
Lopez-Vilella R, Donoso Trenado V, Jover Pastor P, Sanchez-Lazaro I, Dolz L, Almenar Bonet L
Life (Basel)
. 2022 Nov;
12(11).
PMID: 36362983
Background. This study aims to determine whether the administration of ferric carboxymaltose (FCM) in patients with acute heart failure (AHF) and iron deficiency (ID) improves morbidity and mortality. Methods. We...
15.
Lopez-Vilella R, Gomez Bueno M, Gonzalez Vilchez F, Sole Jover A, Laporta Hernandez R, Guillen R, et al.
Transplant Proc
. 2022 Nov;
54(9):2500-2502.
PMID: 36319494
Background: The outcomes of heart-lung transplant (HLT) are worse than those of heart transplant (HT) and lung transplant alone; this and the availability of mechanical assistance have meant that the...
16.
Lopez-Vilella R, Laymito Quispe R, Donoso-Trenado V, Sanchez-Lazaro I, Dolz L, Almenar Bonet L
Transplant Proc
. 2022 Nov;
54(9):2497-2499.
PMID: 36319493
Background: In advanced heart failure (HF), each hospitalization for decompensation is a vulnerable moment, and it requires optimizing pharmacologic treatment. This study aimed to analyze changes in the pharmacologic treatment...
17.
Lopez-Vilella R, Donoso Trenado V, Guerrero Cervera B, Sanchez-Lazaro I, Almenar Bonet L
Eur J Intern Med
. 2022 Jun;
104:128-130.
PMID: 35773170
No abstract available.
18.
Esteban-Fernandez A, Ortiz Cortes C, Lopez-Fernandez S, Recio Mayoral A, Camacho Jurado F, Gomez Otero I, et al.
ESC Heart Fail
. 2022 Jun;
9(5):3071-3078.
PMID: 35748119
Aims: Hyperkalaemia (HK) is common in heart failure (HF) patients, related to renal dysfunction and medical treatment. It limits medical therapy optimization, which impacts prognosis. New potassium (K) binders help...
19.
Lopez-Vilella R, Sanchez-Lazaro I, Guerrero Cervera B, Donoso Trenado V, Soldevila Orient A, Almenar Bonet L
Rev Esp Cardiol (Engl Ed)
. 2022 Jun;
76(1):60-62.
PMID: 35667562
No abstract available.
20.
Lopez-Vilella R, Lozano-Edo S, Arenas Martin P, Jover-Pastor P, Ezzitouny M, Sorolla Romero J, et al.
ESC Heart Fail
. 2021 Dec;
9(1):133-145.
PMID: 34964300
Aims: Heart failure (HF) is a proinflammatory disease often associated with the onset of iron deficiency (ID). ID alters mitochondrial function, reducing the generation of cellular energy in skeletal muscle...